Planning Capital Management Corporation’s Regeneron Pharmaceuticals REGN Stock Holding History

Planning Capital Management Corporation’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$12.6K	Buy	+12	New	+$13.4K	0.01%	403

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Planning Capital Management Corporation's REGN Position: Q3 2024 in Review

Planning Capital Management Corporation opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2024: 12 shares worth $12.6K. The stake represents 0.01% of the portfolio and ranks #403 among its holdings.

1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Planning Capital Management Corporation held 12 shares of Regeneron Pharmaceuticals worth $12.6K as of Q3 2024.
Regeneron Pharmaceuticals was a new Planning Capital Management Corporation position in Q3 2024.
Regeneron Pharmaceuticals made up 0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #403 holding.
1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.